Northwest Biotherapeutics reported $1.52M in Interest Expense on Debt for its fiscal quarter ending in March of 2024.





Interest Expense On Debt Change Date
Agenus USD 14.67M 1.35M Mar/2026
AstraZeneca USD 340M 144M Jun/2026
Bristol-Myers Squibb USD 407M 4M Jun/2026
Eisai JPY 1.96B 409M Jun/2026
Merck USD 525M 46M Jun/2026
Northwest Biotherapeutics USD 1.52M 276K Mar/2024
Pfizer USD 667M 4M Jun/2026
Plus Therapeutics USD 62K 25K Dec/2023
Roche Holding CHF 304M 7.5M Jun/2025